Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 253

1.

Osteopontin expression according to molecular profile of invasive breast cancer: a clinicopathological and immunohistochemical study.

Ribeiro-Silva A, Oliveira da Costa JP.

Int J Biol Markers. 2008 Jul-Sep;23(3):154-60.

PMID:
18949741
2.

Osteopontin and p53 expression are associated with tumor progression in a case of synchronous, bilateral, invasive mammary carcinomas.

Tuck AB, O'Malley FP, Singhal H, Tonkin KS, Harris JF, Bautista D, Chambers AF.

Arch Pathol Lab Med. 1997 Jun;121(6):578-84.

PMID:
9199622
3.
4.

Prognostic significance of the metastasis-associated protein osteopontin in human breast cancer.

Rudland PS, Platt-Higgins A, El-Tanani M, De Silva Rudland S, Barraclough R, Winstanley JH, Howitt R, West CR.

Cancer Res. 2002 Jun 15;62(12):3417-27.

5.

Expression and prognostic significance of metalloproteases and their inhibitors in luminal A and basal-like phenotypes of breast carcinoma.

González LO, Corte MD, Junquera S, González-Fernández R, del Casar JM, García C, Andicoechea A, Vázquez J, Pérez-Fernández R, Vizoso FJ.

Hum Pathol. 2009 Sep;40(9):1224-33. doi: 10.1016/j.humpath.2008.12.022. Epub 2009 May 12.

PMID:
19439346
6.
7.

CD24 expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study.

Bircan S, Kapucuoglu N, Baspinar S, Inan G, Candir O.

Pathol Res Pract. 2006;202(8):569-76. Epub 2006 Jul 7.

PMID:
16828238
8.

Vascular endothelial growth factor expression in the basal subtype of breast carcinoma.

Ribeiro-Silva A, Ribeiro do Vale F, Zucoloto S.

Am J Clin Pathol. 2006 Apr;125(4):512-8.

9.

Increased expression of osteopontin in patients with triple-negative breast cancer.

Wang X, Chao L, Ma G, Chen L, Tian B, Zang Y, Sun J.

Eur J Clin Invest. 2008 Jun;38(6):438-46. doi: 10.1111/j.1365-2362.2008.01956.x. Epub 2008 Apr 30.

PMID:
18452545
10.

Expression of CD133, PAX2, ESA, and GPR30 in invasive ductal breast carcinomas.

Liu Q, Li JG, Zheng XY, Jin F, Dong HT.

Chin Med J (Engl). 2009 Nov 20;122(22):2763-9.

PMID:
19951611
11.

RET finger protein expression in invasive breast carcinoma: relationship between RFP and ErbB2 expression.

Tezel GG, Uner A, Yildiz I, Guler G, Takahashi M.

Pathol Res Pract. 2009;205(6):403-8. doi: 10.1016/j.prp.2008.12.014. Epub 2009 Feb 20.

PMID:
19232840
12.

p63 correlates with both BRCA1 and cytokeratin 5 in invasive breast carcinomas: further evidence for the pathogenesis of the basal phenotype of breast cancer.

Ribeiro-Silva A, Ramalho LN, Garcia SB, Brandão DF, Chahud F, Zucoloto S.

Histopathology. 2005 Nov;47(5):458-66.

PMID:
16241993
13.

Correlation of osteopontin protein expression and pathological stage across a wide variety of tumor histologies.

Coppola D, Szabo M, Boulware D, Muraca P, Alsarraj M, Chambers AF, Yeatman TJ.

Clin Cancer Res. 2004 Jan 1;10(1 Pt 1):184-90.

14.

[Expression and significance of Bmi-1 in breast cancer].

Feng Y, Song LB, Guo BH, Liao WT, Li MZ, Liu WL, Zeng MS, Zhang L.

Ai Zheng. 2007 Feb;26(2):154-7. Chinese.

PMID:
17298744
15.

Expression of the epidermal growth factor receptor (EGFR) and the phosphorylated EGFR in invasive breast carcinomas.

Magkou C, Nakopoulou L, Zoubouli C, Karali K, Theohari I, Bakarakos P, Giannopoulou I.

Breast Cancer Res. 2008;10(3):R49. doi: 10.1186/bcr2103. Epub 2008 Jun 3.

16.

Expression of basal and luminal cytokeratins in breast cancer and their correlation with clinicopathological prognostic variables.

Mohammadizadeh F, Naimi A, Rajabi P, Ghasemibasir H, Eftekhari A.

Indian J Med Sci. 2009 Apr;63(4):152-62. doi: 10.4103/0019-5359.50764.

17.

Expression of osteopontin and CDX2: indications of phenotypes and prognosis in advanced gastric cancer.

Zhang X, Tsukamoto T, Mizoshita T, Ban H, Suzuki H, Toyoda T, Tatematsu M.

Oncol Rep. 2009 Mar;21(3):609-13.

PMID:
19212618
18.

Bone metastasis is strongly associated with estrogen receptor-positive/progesterone receptor-negative breast carcinomas.

Wei B, Wang J, Bourne P, Yang Q, Hicks D, Bu H, Tang P.

Hum Pathol. 2008 Dec;39(12):1809-15. doi: 10.1016/j.humpath.2008.05.010. Epub 2008 Aug 19.

PMID:
18715613
19.
20.

CD109 expression in basal-like breast carcinoma.

Hasegawa M, Moritani S, Murakumo Y, Sato T, Hagiwara S, Suzuki C, Mii S, Jijiwa M, Enomoto A, Asai N, Ichihara S, Takahashi M.

Pathol Int. 2008 May;58(5):288-94. doi: 10.1111/j.1440-1827.2008.02225.x.

PMID:
18429827
Items per page

Supplemental Content

Write to the Help Desk